<?xml version="1.0" encoding="UTF-8"?>
<ref id="B138-jcm-09-01917">
 <label>138.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Solaimanzadeh</surname>
    <given-names>I.</given-names>
   </name>
  </person-group>
  <article-title>Acetazolamide, Nifedipine and Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the Treatment of Coronavirus Disease 2019 (COVID-19)</article-title>
  <source>Cureus</source>
  <year>2020</year>
  <volume>12</volume>
  <fpage>e7343</fpage>
  <pub-id pub-id-type="doi">10.7759/cureus.7343</pub-id>
  <pub-id pub-id-type="pmid">32226695</pub-id>
 </element-citation>
</ref>
